Health Products

Apo-Diltiaz CD (2013-12-17)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
KK3943B. Apo-Diltiaz CD 240 mg
Recalling Firm
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
Marketing Authorization Holder
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
Controlled Delivery CapsulesDIN 02230999240 mg
KK3945C. Apo-Diltiaz CD 120 mg
Recalling Firm
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
Marketing Authorization Holder
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
Controlled Delivery CapsulesDIN 02230997120 mg
KH1024A. Apo-Diltiaz CD 180 mg
Recalling Firm
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
Marketing Authorization Holder
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
Controlled Delivery CapsulesDIN 02230998180 mg

Introduction

Recalled products
  1. Apo-Diltiaz CD 180 mg
  2. Apo-Diltiaz CD 240 mg
  3. Apo-Diltiaz CD 120 mg

Reason

Dissolution may not meet specification for 30 hours timepoint over shelf-life.

Depth of distribution

Wholesalers/distributors and retailers in Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Northwest Territories, Ontario, Prince Edward Island, Quebec, Saskatchewan.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime